Markets
← Back to Stocks
DGX
QUEST DIAGNOSTICS INC
Health Care · Health Care Services
$194.24
-0.78%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
Diagnostic services provider powers ahead with analyst support and buy momentum
Quest Diagnostics rose $0.45 in after-hours trading and gained momentum into premarket at $206.80, reflecting positive analyst sentiment with 9 out of 10 analysts recommending buying the stock versus only 1 suggesting a sell. The diagnostics services provider trades with a previous close of $205.35 and shows the 12-month average price target of $212, indicating approximately 3% upside potential. The next earnings report is scheduled for April 28, 2026, providing the next catalyst for investor sentiment.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$21.6B
P/E (TTM)22.2
Forward P/E16.9
Beta0.63
Div Yield176.00%
Prev Close$195.77
RSI (14-Day)
12Oversold
0305070100
52-Week Range
$157.20$194.24$213.50
From High-9.0%
From Low+23.6%
Moving Averages
50d SMA
$195.02-0.4%
200d SMA
$182.31+6.5%
Price between 50d and 200d. Testing 50d support.
Returns
1W
-3.3%
1M
-5.0%
3M
+9.2%
6M
+7.5%
1Y
+14.7%
YTD
+12.3%
Volume
Today36K
20d Avg751K
Ratio0.05x